|
Quotes & Info
|
| LH > SEC Filings for LH > Form 8-K on 10-Dec-2008 | All Recent SEC Filings |
10-Dec-2008
Regulation FD Disclosure
On December 10, 2008, National Jewish Health and Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) (LabCorp) announced they have reached an agreement to collaborate in the development and commercialization of molecular diagnostic tests in support of personalized medicine. The collaboration combines National Jewish Health's strengths in molecular diagnostics and respiratory, immune, and related diseases with LabCorp's national leadership in personalized medicine and esoteric testing.
Exhibits
99.1 Press Release dated December 10, 2008
|
|